AbbVie lifts 2026 EPS guidance, closes Apogee deal, posts Skyrizi and Juvmo approvalsNov 12M&AAbbVieBiovie Inc.Updated
Bristol Myers Squibb drops Prothena's PRX019 after internal reviewOct 29PartnershipBristol Myers SquibbProthena Corp Public Ltd Co
Prothena's chief development officer to resign, join partner companyOct 2PeopleProthena Corp Public Ltd Co
Prothena reports Q2 2026 results, updates year-end cash guidance to $259 millionAug 6Quarterly updateProthena Corp Public Ltd Co